Biotech · Private company · Monmouth Junction, NJ, US
Ayala Pharmaceuticals, Inc.
SEC CIK 0001100397
Track this companyFree. Adds Ayala Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- AL101Phase 2 · Adenoid Cystic CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AL101Phase 2 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Understanding the Burden of ACC Through the Eyes of PatientsCOMPLETED · started Jan 11, 2021ClinicalTrials.gov NCT04706845 · fetched Nov 12, 2026
- A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast CancerPHASE2 · TERMINATED · started Aug 14, 2020ClinicalTrials.gov NCT04461600 · fetched Nov 12, 2026
- A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch MutationsPHASE2 · COMPLETED · started Dec 14, 2018ClinicalTrials.gov NCT03691207 · fetched Nov 12, 2026